The Effects of COVID-19 Pandemic on the Follow-Up and Treatment Process of Gynecological Cancers and Breast Cancer

Aydin Dogan R., GÜDÜCÜ N.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, vol.36, no.1, pp.133-138, 2021 (ESCI) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 36 Issue: 1
  • Publication Date: 2021
  • Doi Number: 10.5505/tjo.2020.2401
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, EMBASE, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.133-138
  • Istanbul University Affiliated: No


The present review was written to describe the effects of the COVID-19 pandemic on followup and treatment process of gynecological cancers and breast cancer in accordance with current literature, guidelines from national and international cancer associations. Recommendations were provided based on the consensus conference model. In the follow-up and treatment process of gynecological cancers and breast cancer, there are many factors, such as the clinical course of patient, the possibility of an emergency of the patient, the stage of the cancer and the current status of the chemotherapies. Although opinions in all types of cancer differ among themselves, general beliefs are postponement of non-urgent surgical operations, re-evaluation of chemotherapy processes, postponing appointments for new non-urgent diagnoses, reducing the length of hospital stay of patients in emergency procedures, conducting consultations by telemedicine or telephone, treatment of patients with COVID-19 suspicions after 15 days, planning biopsies or surgeries according to the staging status of cancers and planning conferences as video conferences in cases that require a multidisciplinary approach. Patients diagnosed with cancer during the COVID-19 pandemic should not be lost, followup and treatment should be continued without disruption, patients should be remembered to be in the high-risk group in this process and necessary hygiene measures should be taken in both follow-up and treatment concerning risks and COVID-19 pandemics.